Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines.

[1]  L. Cosmi,et al.  Assessment of chemokine receptor expression by human Th1 and Th2 cells in vitro and in vivo , 1999, Journal of leukocyte biology.

[2]  K. Matsushima,et al.  Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. , 1999, International immunology.

[3]  M. Reale,et al.  Intramuscular injection of hrRANTES causes mast cell recruitment and increased transcription of histidine decarboxylase in mice: lack of effects in genetically mast cell‐deficient W/WV mice , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  L. Cosmi,et al.  Enhanced HIV expression during Th2‐oriented responses explained by the opposite regulatory effect of IL‐4 and IFN‐γ on fusin/CXCR4 , 1998, European journal of immunology.

[5]  T. Standiford,et al.  Novel role of transmembrane SCF for mast cell activation and eotaxin production in mast cell-fibroblast interactions. , 1998, Journal of immunology.

[6]  A. Luster,et al.  Chemokines--chemotactic cytokines that mediate inflammation. , 1998, The New England journal of medicine.

[7]  P. Allavena,et al.  Differential Expression of Chemokine Receptors and Chemotactic Responsiveness of Type 1 T Helper Cells (Th1s) and Th2s , 1998, The Journal of experimental medicine.

[8]  P. Allavena,et al.  Chemokines and chemokine receptors during activation and deactivation of monocytes and dendritic cells and in amplification of Th1 versus Th2 responses , 1998, International journal of clinical & laboratory research.

[9]  F. Annunziato,et al.  High CD30 ligand expression by epithelial cells and Hassal's corpuscles in the medulla of human thymus. , 1998, Blood.

[10]  J. Gutiérrez-Ramos,et al.  Eotaxin modulates myelopoiesis and mast cell development from embryonic hematopoietic progenitors. , 1998, Blood.

[11]  C. Mackay,et al.  Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co‐localization of eotaxin mRNA to bronchial epithelial and endothelial cells , 1997, European journal of immunology.

[12]  G. Pizzolo,et al.  Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis. , 1997, The American journal of pathology.

[13]  C. Mackay,et al.  Functional expression of the eotaxin receptor CCR3 in T lymphocytes co-localizing with eosinophils , 1997, Current Biology.

[14]  C. Mackay,et al.  Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. , 1997, Science.

[15]  C. Mackay,et al.  High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. , 1997, The Journal of clinical investigation.

[16]  Y. Kitamura,et al.  Expression of mast-cell-specific proteases in tissues of mice studied by in situ hybridization. , 1997, The American journal of pathology.

[17]  M. Welle.  Development, significance, and heterogeneity of mast cells with particular regard to the mast cell‐specific proteases chymase and tryptase , 1997, Journal of leukocyte biology.

[18]  S. Topino,et al.  Kaposi's sarcoma cells express the macrophage-associated antigen mannose receptor and develop in peripheral blood cultures of Kaposi's sarcoma patients. , 1997, The American journal of pathology.

[19]  B Dewald,et al.  Human chemokines: an update. , 1997, Annual review of immunology.

[20]  G. Marone,et al.  Cyclosporin H is a potent and selective competitive antagonist of human basophil activation by N-formyl-methionyl-leucyl-phenylalanine. , 1996, The Journal of allergy and clinical immunology.

[21]  E. Arbustini,et al.  Human synovial mast cells. I. Ultrastructural in situ and in vitro immunologic characterization. , 1996, Arthritis and rheumatism.

[22]  C. Mackay,et al.  Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils , 1996, The Journal of experimental medicine.

[23]  J. Demartino,et al.  Cloning, expression, and characterization of the human eosinophil eotaxin receptor , 1996, The Journal of experimental medicine.

[24]  C. Combadière,et al.  Molecular Cloning of Human Eotaxin, an Eosinophil-selective CC Chemokine, and Identification of a Specific Eosinophil Eotaxin Receptor, CC Chemokine Receptor 3 (*) , 1996, The Journal of Biological Chemistry.

[25]  B. Zweiman,et al.  The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. , 1995, The Journal of clinical investigation.

[26]  P. Leder,et al.  Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[27]  G. Marone,et al.  Human heart mast cells: a definitive case of mast cell heterogeneity. , 1995, International archives of allergy and immunology.

[28]  E. Arbustini,et al.  Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization. , 1995, Journal of immunology.

[29]  V. Casolaro,et al.  The antineoplastic bryostatins affect human basophils and mast cells differently. , 1995, Blood.

[30]  N. Weidner,et al.  Heterogeneity of mast cells at multiple body sites. Fluorescent determination of avidin binding and immunofluorescent determination of chymase, tryptase, and carboxypeptidase content. , 1993, Pathology, research and practice.

[31]  S. Galli,et al.  New concepts about the mast cell. , 1993, The New England journal of medicine.

[32]  S. Durham,et al.  Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. , 1992, The New England journal of medicine.

[33]  A. Dvorak,et al.  Development of human mast cells in vitro. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[34]  C. Kepley,et al.  Detection of MCT and MCTC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[35]  S. Peters,et al.  An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils. , 1989, The Journal of pharmacology and experimental therapeutics.

[36]  D. McDonald,et al.  Chymase and tryptase in dog mastocytoma cells: asynchronous expression as revealed by enzyme cytochemical staining. , 1988, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[37]  J. Marshall,et al.  Formalin sensitivity and differential staining of mast cells in human dermis , 1987, The British journal of dermatology.

[38]  C. Elson,et al.  Deficiency of the tryptase-positive, chymase-negative mast cell type in gastrointestinal mucosa of patients with defective T lymphocyte function. , 1987, Journal of immunology.

[39]  R. Stead,et al.  Intestinal mucosal mast cells in normal and nematode-infected rat intestines are in intimate contact with peptidergic nerves. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Y. Kitamura,et al.  Mutual phenotypic changes between connective tissue type and mucosal mast cells. , 1987, International archives of allergy and applied immunology.

[41]  L. Schwartz,et al.  Two types of human mast cells that have distinct neutral protease compositions. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Y. Kitamura,et al.  Probable dedifferentiation of mast cells in mouse connective tissues. , 1986, Current topics in developmental biology.

[43]  J. Bienenstock,et al.  Mast cell heterogeneity in man. I. Histologic studies of the intestine. , 1985, International archives of allergy and applied immunology.

[44]  R. Siraganian.  An automated continuous-flow system for the extraction and fluorometric analysis of histamine. , 1974, Analytical biochemistry.

[45]  L. Enerbäck,et al.  Mast cells in rat gastrointestinal mucosa. 2. Dye-binding and metachromatic properties. , 1966, Acta pathologica et microbiologica Scandinavica.

[46]  L. Enerbäck,et al.  Mast cells in rat gastrointestinal mucosa. 4. Monoamine storing capacity. , 1966, Acta pathologica et microbiologica Scandinavica.

[47]  L. Enerbäck,et al.  Mast cells in rat gastrointestinal mucosa. I. Effects of fixation. , 1966, Acta pathologica et microbiologica Scandinavica.